Nitric Oxide and Systemic and Renal Hemodynamic Disturbances in Cirrhosis

Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment: Second Edition

Volumn , Issue , 2007, Pages 105-114

  Morales Ruiz, Manuel ^a   Jiménez, Wladimiro ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Catalysis; Cirrhosis; Neurotoxicity; Nitric oxide; Soluble guanylate cyclase (sGC)

Indexed keywords

EID: 78049482211     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987476.ch8     Document Type: Chapter

References (99)

1. Ignarro LJ, Adams JB, Horwitz PM, Wood KS. Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-defi cient enzyme forms. J Biol Chem 1986; 261:4997-5002.
2. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351:714-18.
3. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 1992; 89:6711-15.
4. Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 1992; 267:6370-4.
5. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992; 89:6348-52.
6. Sessa WC, Harrison JK, Barber CM et al. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem 1992; 267:15274-6.
7. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 1994; 63:175-95.
8. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993; 75:1273-86.
9. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-42.
10. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6:3051-64.
11. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 2003; 284:R1-12.
12. Vallance P, Leiper J. Blocking NO synthesis: how, where and why? Nat Rev Drug Discov 2002; 1:939-50.
13. Clària J, Jiménez W, Ros J et al. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 1992; 15:343-9.
14. Niederberger M, Martin PY, Ginès P et al. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology 1995; 109:1624-30.
15. Ros J, Jiménez W, Lamas S et al. Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology 1995; 21:554-60.
16. Clària J, Jiménez W, Ros J et al. Increased nitric oxidedependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology 1994; 20:1615-21.
17. Niederberger M, Ginès P, Martin PY et al. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 1996; 24:947-51.
18. Castro A, Jiménez W, Clària J et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology 1993; 18:367-72.
19. Sieber CC, López-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993; 104:1750-4.
20. Sieber CC, Groszmann RJ. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Physiol 1992; 262:G996-1001.
21. Lee FY, Albillos A, Colombato LA, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology 1992; 16:1043-8.
22. Hartleb M, Moreau R, Cailmail S, Gaudin C, Lebrec D. Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis. Gastroenterology 1994; 107:1085-93.
23. Martin PY, Xu DL, Niederberger M et al. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol 1996; 270: F494-F499.
24. Morales-Ruiz M, Jiménez W, Pérez-Sala D et al. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 1996; 24:1481-6.
25. Xu L, Carter EP, Ohara M et al. Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis. Am J Physiol Renal Physiol 2000; 279:F1110-F1115.
26. Cahill PA, Foster C, Redmond EM, Gingalewski C, Wu Y, Sitzmann JV. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology 1995; 22:598-606.
27. Cahill PA, Redmond EM, Hodges R, Zhang S, Sitzmann JV. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J Hepatol 1996; 25:370-8.
28. Heller J, Sogni P, Tazi KA et al. Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration. Hepatology 1999; 30:698-704.
29. Liu H, Song D, Lee SS. Increased nitric oxide synthase expression in aorta of cirrhotic rats. Life Sci 1999; 64:1753-9.
30. Tazi KA, Barriere E, Moreau R et al. Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis. Gastroenterology 2002; 122:1869-77.
31. Stumm MM, D'Orazio D, Sumanovski LT, Martin PY, Reichen J, Sieber CC. Endothelial, but not the inducible, nitric oxide synthase is detectable in normal and portal hypertensive rats. Liver 2002; 22:441-50.
32. Iwakiri Y, Cadelina G, Sessa WC, Groszmann RJ. Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension. Am J Physiol Gastrointest Liver Physiol 2002; 283:G1074-G1081.
33. Theodorakis NG, Wang YN, Skill NJ et al. The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: studies in gene-knockout mice. Gastroenterology 2003; 124:1500-8.
34. Albillos A, Rossi I, Cacho G et al. Enhanced endotheliumdependent vasodilation in patients with cirrhosis. Am J Physiol 1995; 268:G459-G464.
35. Guarner C, Soriano G, Tomás A et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993; 18:1139-43.
36. Sarela AI, Mihaimeed FM, Batten JJ, Davidson BR, Mathie RT. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis. Gut 1999; 44:749-53.
37. Battista S, Bar F, Mengozzi G, Zanon E, Grosso M, Molino G. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins. J Hepatol 1997; 26:75-80.
38. Albornoz L, Motta A, Alvarez D et al. Nitric oxide synthase activity in the splanchnic vasculature of patients with cirrhosis: relationship with hemodynamic disturbances. J Hepatol 2001; 35:452-6.
39. Matsumoto A, Ogura K, Hirata Y et al. Increased nitric oxide in the exhaled air of patients with decompensated liver cirrhosis. Ann Intern Med 1995; 123:110-13.
40. Sogni P, Garnier P, Gadano A et al. Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis. J Hepatol 1995; 23:471-3.
41. Criado-Jiménez M, Rivas-Cabanero L, Martin-Oterino JA, López-Novoa JM, Sanchez-Rodríguez A. Nitric oxide production by mononuclear leukocytes in alcoholic cirrhosis. J Mol Med 1995; 73:31-3.
42. Laffi G, Foschi M, Masini E et al. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology 1995; 22:1666-73.
43. Jiménez W, Ros J, Morales-Ruiz M et al. Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients. Hepatology 1999; 30:670-6.
44. Morales-Ruiz M, Jimenez W, Ros J et al. Nitric oxide production by peritoneal macrophages of cirrhotic rats: a host response against bacterial peritonitis. Gastroenterology 1997; 112:2056-64.
45. Campillo B, Chabrier PE, Pelle G et al. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology 1995; 22:1423-9.
46. La Villa G, Barletta G, Pantaleo P et al. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis. Hepatology 2001; 34:19-27.
47. Thiesson HC, Skott O, Jespersen B, Schaffalitzky de Muckadell OB. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites. Am J Gastroenterol 2003; 98:180-6.
48. Fernández-Varo G, Ros J, Morales-Ruiz M et al. Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis. Am J Pathol 2003; 162:1985-93.
49. Zhang B, Borderie D, Sogni P, Soubrane O, Houssin D, Calmus Y. NO-mediated vasodilation in the rat liver. Role of hepatocytes and liver endothelial cells. J Hepatol 1997; 26:1348-55.
50. Bauer C, Walcher F, Kalweit U, Larsen R, Marzi I. Role of nitric oxide in the regulation of the hepatic microcirculation in vivo. J Hepatol 1997; 27:1089-95.
51. Mittal MK, Gupta TK, Lee FY, Sieber CC, Groszmann RJ. Nitric oxide modulates hepatic vascular tone in normal rat liver. Am J Physiol 1994; 267:G416-G422.
52. Shah V, Haddad FG, Garcia-Cardena G et al. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest 1997; 100:2923-30.
53. Gupta TK, Toruner M, Chung MK, Groszmann RJ. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 1998; 28:926-31.
54. Rockey DC, Chung JJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 1998; 114:344-51.
55. Hendrickson H, Chatterjee S, Cao S, Morales-Ruiz M, Sessa WC, Shah V. Infl uence of caveolin on constitutively activated recombinant eNOS: insights into eNOS dysfunction in BDL rat liver. Am J Physiol Gastrointest Liver Physiol 2003; 285: G652-G660.
56. Shah V, Toruner M, Haddad F et al. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology 1999; 117:1222-8.
57. Shah V, Cao S, Hendrickson H, Yao J, Katusic ZS. Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats. Am J Physiol Gastrointest Liver Physiol 2001; 280:G1209-G1216.
58. Yokomori H, Oda M, Ogi M, Sakai K, Ishii H. Enhanced expression of endothelial nitric oxide synthase and caveolin-1 in human cirrhosis. Liver 2002; 22:150-8.
59. Morales-Ruiz M, Cejudo-Martin P, Fernández-Varo G et al. Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats. Gastroenterology 2003; 125:522-31.
60. Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 2001; 299:818-24.
61. Rolla G, Brussino L, Colagrande P et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology 1997; 26:842-7.
62. Cremona G, Higenbottam TW, Mayoral V et al. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 1995; 8:1883-5.
63. Delclaux C, Mahut B, Zerah-Lancner F et al. Increased nitric oxide output from alveolar origin during liver cirrhosis versus bronchial source during asthma. Am J Resp Crit Care Med 2002; 165:332-7.
64. Cremona G, Higenbottam T, Borland C, Mist B. Mixed expired nitric oxide in primary pulmonary hypertension in relation to lung diffusion capacity. Q J Med 1994; 87:547-51.
65. Rolla G, Brussino L, Colagrande P et al. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med 1998; 129: 375-8.
66. Fallon MB, Abrams GA, Luo B, Hou Z, Dai J, Ku DD. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 1997; 113:606-14.
67. Carter EP, Sato K, Morio Y, McMurtry IF. Inhibition of K(Ca) channels restores blunted hypoxic pulmonary vasoconstriction in rats with cirrhosis. Am J Physiol Lung Cell Mol Physiol 2000; 279:L903-L910.
68. Mizumoto M, Arii S, Furutani M et al. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis. J Surg Res 1997; 70:124-33.
69. Nelson RS, Eichinger MR. Role of nitric oxide (NO) in pulmonary dysfunction associated with experimental cirrhosis. Respir Physiol 2001; 126:65-74.
70. Nunes H, Lebrec D, Mazmanian M et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Resp Crit Care Med 2001; 164:879-85.
71. Blendis L, Wong F. Is there a cirrhotic cardiomyopathy? Am J Gastroenterol 2000; 95:3026-8.
72. Laffi G, Barletta G, La Villa G et al. Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. Gastroenterology 1997; 113:891-8.
73. Moller S, Sondergaard L, Mogelvang J, Henriksen O, Henriksen JH. Decreased right heart blood volume determined by magnetic resonance imaging: evidence of central underfi lling in cirrhosis. Hepatology 1995; 22: 472-8.
74. Kelbaek H, Eriksen J, Brynjolf I et al. Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver. Am J Cardiol 1984; 54:852-5.
75. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24:451-9.
76. Pozzi M, Carugo S, Boari G et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26:1131-7.
77. Van Obbergh L, Vallieres Y, Blaise G. Cardiac modifi cations occurring in the ascitic rat with biliary cirrhosis are nitric oxide related. J Hepatol 1996; 24:747-52.
78. Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile ductligated rats. Gastroenterology 2000; 118:937-44.
79. Arroyo V, Jiménez W. Renal function in liver disease. In: Greenberg A, Coffman TM, eds. Primer on Kidney Diseases, 3rd edn. San Diego, CA: Academic Press, 2001; 188-94.
80. Atucha NM, Garcia-Estan J, Ramirez A, Pérez MC, Quesada T, Romero JC. Renal effects of nitric oxide synthesis inhibition in cirrhotic rats. Am J Physiol 1994; 267:R1454-R1460.
81. Ros J, Clària J, Jiménez W et al. Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis. Hepatology 1995; 22:915-20.
82. Ramírez A, Atucha NM, Pérez MC et al. Efectos de la inhibición de la síntesis de oxido nítrico en la hemodinámica y excreción renal de ratas con cirrosis biliar primaria. Nefrología 1994; 14:656-62.
83. Martin PY, Ohara M, Ginès P et al. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. J Clin Invest 1998; 101:235-42.
84. Atucha NM, Garcia-Estan J. Intrarenal alterations in experimental liver cirrhosis. News Physiol Sci 1996; 11:48-52.
85. Kanwar S, Kubes P, Tepperman BL, Lee SS. Nitric oxide synthase activity in portal-hypertensive and cirrhotic rats. J Hepatol 1996; 25:85-9.
86. Criado M, Flores O, Ortiz MC et al. Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: role of inducible nitric oxide synthase activation. Hepatology 1997; 26:268-76.
87. Porst M, Hartner A, Krause H, Hilgers KF, Veelken R. Inducible nitric oxide synthase and glomerular hemodynamics in rats with liver cirrhosis. Am J Physiol Renal Physiol 2001; 281:F293-F299.
88. Bosch-Marcé M, Morales-Ruiz M, Jiménez W et al. Increased renal expression of nitric oxide synthase type III in cirrhotic rats with ascites. Hepatology 1998; 27:1191-9.
89. Garcia-Estan J, Atucha NM, Sabio JM, Vargas F, Quesada T, Romero JC. Increased endothelium-dependent renal vasodilation in cirrhotic rats. Am J Physiol 1994; 267:R549-R553.
90. Guarner C, Soriano G. Spontaneous bacterial peritonitis. Semin Liver Dis 1997; 17:203-17.
91. Rimola A, Navasa M. Infections in liver disease. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodes J, eds. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, 1999; 1862-74.
92. Navasa M, Follo A, Filella X et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998; 27:1227-32.
93. Coskun U, Ozenirler S, Sancak B, Bukan N. Serum and ascitic fl uid nitrate levels in patients with cirrhosis. Clin Chim Acta 2001; 306:127-32.
94. Bories PN, Campillo B, Azaou L, Scherman E. Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1997; 25:1328-33.
95. Bories PN, Campillo B, Scherman E. Up-regulation of nitric oxide production by interferon-gamma in cultured peritoneal macrophages from patients with cirrhosis. Clin Sci (Lond) 1999; 97:399-406.
96. Groszmann RJ. Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly. Gastroenterology 1997; 113:1794-7.
97. Fiorucci S, Antonelli E, Morelli O et al. NCX-1000, a NOreleasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci USA 2001; 98:8897-902.
98. Yu Q, Shao R, Qian HS, George SE, Rockey DC. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension. J Clin Invest 2000; 105:741-8.
99. Van de Casteele M, Omasta A, Janssens S et al. In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats. Gut 2002; 51:440-5.